Acadia Healthcare (NASDAQ:ACHC) Shares Gap Down After Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) gapped down before the market opened on Thursday after Bank of America lowered their price target on the stock from $105.00 to $90.00. The stock had previously closed at $72.99, but opened at $70.14. Bank of America currently has a buy rating on the stock. Acadia Healthcare shares last traded at $69.04, with a volume of 323,695 shares trading hands.

Several other research analysts have also issued reports on the company. UBS Group increased their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. TD Cowen lifted their price target on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a report on Thursday, April 25th. Finally, Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a report on Friday, January 5th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.90.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC bought a new stake in shares of Acadia Healthcare in the 4th quarter worth about $26,000. Headlands Technologies LLC bought a new stake in Acadia Healthcare during the third quarter worth approximately $25,000. Mather Group LLC. purchased a new stake in Acadia Healthcare during the first quarter valued at approximately $48,000. Fifth Third Bancorp lifted its stake in shares of Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in shares of Acadia Healthcare in the 3rd quarter worth approximately $96,000.

Acadia Healthcare Stock Down 7.9 %

The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The company has a fifty day moving average of $77.49 and a two-hundred day moving average of $77.68. The company has a market cap of $6.22 billion, a PE ratio of -269.63, a price-to-earnings-growth ratio of 2.18 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. During the same period in the prior year, the business posted $0.75 earnings per share. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.